# Immunomodulatory Effect of Dexmedetomidine as an Adjuvant Drug in Laparoscopic Cholecystectomies

> **NCT05489900** · PHASE3 · UNKNOWN · sponsor: **Universidade Federal do Rio de Janeiro** · enrollment: 52 (estimated)

## Conditions studied

- Physiological Effects of Drugs

## Interventions

- **DRUG:** Dexmedetomidine Hydrochloride

## Key facts

- **NCT ID:** NCT05489900
- **Lead sponsor:** Universidade Federal do Rio de Janeiro
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-01
- **Primary completion:** 2022-07-31
- **Final completion:** 2022-10-31
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2022-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05489900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05489900, "Immunomodulatory Effect of Dexmedetomidine as an Adjuvant Drug in Laparoscopic Cholecystectomies". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05489900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*